478 related articles for article (PubMed ID: 11238375)
21. Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
Yi AK; Krieg AM
J Immunol; 1998 Nov; 161(9):4493-7. PubMed ID: 9794373
[TBL] [Abstract][Full Text] [Related]
22. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter.
Kaminuma O; Deckert M; Elly C; Liu YC; Altman A
Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617
[TBL] [Abstract][Full Text] [Related]
23. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
24. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
25. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
Hussain S; Kilbey A; Gillespie DA
Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
[TBL] [Abstract][Full Text] [Related]
26. Characterization of platelet-derived growth factor-induced p38 mitogen-activated protein kinase activation in vascular smooth muscle cells.
Yamaguchi H; Igarashi M; Hirata A; Tsuchiya H; Susa S; Tominaga M; Daimon M; Kato T
Eur J Clin Invest; 2001 Aug; 31(8):672-80. PubMed ID: 11473568
[TBL] [Abstract][Full Text] [Related]
27. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
Sugimoto T; Stewart S; Han M; Guan KL
EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
[TBL] [Abstract][Full Text] [Related]
28. Contribution of MAP kinase pathways to the activation of ATF-2 in human neuroblastoma cells.
Tindberg N; Porsmyr-Palmertz M; Simi A
Neurochem Res; 2000 Apr; 25(4):527-31. PubMed ID: 10823586
[TBL] [Abstract][Full Text] [Related]
29. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
Kato Y; Kravchenko VV; Tapping RI; Han J; Ulevitch RJ; Lee JD
EMBO J; 1997 Dec; 16(23):7054-66. PubMed ID: 9384584
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.
Aznar S; Valerón PF; del Rincon SV; Pérez LF; Perona R; Lacal JC
Mol Biol Cell; 2001 Oct; 12(10):3282-94. PubMed ID: 11598209
[TBL] [Abstract][Full Text] [Related]
31. Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity.
Visconti R; Gadina M; Chiariello M; Chen EH; Stancato LF; Gutkind JS; O'Shea JJ
Blood; 2000 Sep; 96(5):1844-52. PubMed ID: 10961885
[TBL] [Abstract][Full Text] [Related]
32. The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pak-independent signaling pathway.
Teramoto H; Crespo P; Coso OA; Igishi T; Xu N; Gutkind JS
J Biol Chem; 1996 Oct; 271(42):25731-4. PubMed ID: 8824197
[TBL] [Abstract][Full Text] [Related]
33. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways.
Westwick JK; Lambert QT; Clark GJ; Symons M; Van Aelst L; Pestell RG; Der CJ
Mol Cell Biol; 1997 Mar; 17(3):1324-35. PubMed ID: 9032259
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway.
Efimova T; LaCelle P; Welter JF; Eckert RL
J Biol Chem; 1998 Sep; 273(38):24387-95. PubMed ID: 9733728
[TBL] [Abstract][Full Text] [Related]
35. p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.
He Z; Cho YY; Liu G; Ma WY; Bode AM; Dong Z
J Biol Chem; 2003 Jul; 278(29):26435-42. PubMed ID: 12748197
[TBL] [Abstract][Full Text] [Related]
36. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
37. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
[TBL] [Abstract][Full Text] [Related]
38. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
Li S; Wattenberg EV
Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
[TBL] [Abstract][Full Text] [Related]
39. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
Deng T; Karin M
Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
[TBL] [Abstract][Full Text] [Related]
40. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38.
Lu X; Nemoto S; Lin A
J Biol Chem; 1997 Oct; 272(40):24751-4. PubMed ID: 9312068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
